13F HOLDINGS REPORT
BIOIMPACT CAPITAL LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000950123-24-008626
Total Value
$643.5M
Positions
44
Other Managers
0
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cullinan Therapeutics, Inc. | CGEM | 7,648,268 | $133.4M | 20.73% |
| 2 | Insmed Incorporated | INSM | 615,391 | $41.2M | 6.41% |
| 3 | Olema Pharmaceuticals, Inc. | OLMA | 2,654,867 | $28.7M | 4.46% |
| 4 | iTeos Therapeutics, Inc. | 46565G104 | 1,745,943 | $25.9M | 4.03% |
| 5 | Crinetics Pharmaceuticals Inc. | CRNX | 557,184 | $25.0M | 3.88% |
| 6 | Madrigal Pharmaceuticals inc | MDGL | 71,185 | $19.9M | 3.10% |
| 7 | Iovance Biotherapeutics Inc | IOVA | 2,366,714 | $19.0M | 2.95% |
| 8 | Natera Inc | NTRA | 174,811 | $18.9M | 2.94% |
| 9 | Mirum Pharmaceuticals Inc | MIRM | 492,569 | $16.8M | 2.62% |
| 10 | Ultragenyx Pharmaceutical Inc | RARE | 380,552 | $15.6M | 2.43% |
| 11 | Moonlake Immunotherapeutics | MLTX | 343,235 | $15.1M | 2.35% |
| 12 | Guardant Health Inc | GH | 500,000 | $14.4M | 2.24% |
| 13 | Disc Medicine Inc | IRON | 305,658 | $13.8M | 2.14% |
| 14 | Alkermes Plc | ALKS | 557,556 | $13.4M | 2.09% |
| 15 | Edgewise Therapeutics Inc | EWTX | 740,661 | $13.3M | 2.07% |
| 16 | ALX Oncology Holdings Inc. | ALXO | 2,180,864 | $13.2M | 2.04% |
| 17 | MORPHIC HOLDING INC | 61775R105 | 369,384 | $12.6M | 1.96% |
| 18 | Lantheus Holdings Inc | LNTH | 150,000 | $12.0M | 1.87% |
| 19 | Revolution Medicines, Inc. | RVMDW | 289,396 | $11.2M | 1.75% |
| 20 | Avadel Pharmaceuticals PLC | 05337M104 | 783,242 | $11.0M | 1.71% |
| 21 | Xeris Biopharma Holdings Inc | XERS | 4,830,526 | $10.9M | 1.69% |
| 22 | Axsome Therapeutics, Inc. | AXSM | 132,312 | $10.7M | 1.66% |
| 23 | Kalvista Pharmaceuticals Inc | KALV | 881,937 | $10.4M | 1.61% |
| 24 | Intellia Therapeutics, Inc. | NTLA | 443,503 | $9.9M | 1.54% |
| 25 | Hillevax Inc | 43157M102 | 645,085 | $9.3M | 1.45% |
| 26 | Akero Therapeutics Inc | 00973Y108 | 385,990 | $9.1M | 1.41% |
| 27 | 89Bio Inc | 282559103 | 1,121,736 | $9.0M | 1.40% |
| 28 | Fulcrum Therapeutics Inc | FULC | 1,444,851 | $9.0M | 1.39% |
| 29 | Sutro Biopharma, Inc. | STRO | 3,043,346 | $8.9M | 1.39% |
| 30 | Scholar Rock Holding Corp | SRRK | 1,028,330 | $8.6M | 1.33% |
| 31 | Relay Therapeutics Inc. | RLAY | 1,274,459 | $8.3M | 1.29% |
| 32 | Cartesian Therapeutics Inc | RNAC | 259,696 | $7.0M | 1.09% |
| 33 | REGENXBIO Inc. | RGNX | 557,076 | $6.5M | 1.01% |
| 34 | VIKING THERAPEUTICS INC | VKTX | 118,960 | $6.3M | 0.98% |
| 35 | Zentalis Pharmaceuticals, Inc. | ZNTL | 1,450,000 | $5.9M | 0.92% |
| 36 | Werewolf Therapeutics, Inc. | HOWL | 2,388,011 | $5.8M | 0.91% |
| 37 | Repare Therapeutics, Inc. | 760273102 | 1,639,849 | $5.4M | 0.84% |
| 38 | Avidity Biosciences Inc | 05370A108 | 125,000 | $5.1M | 0.79% |
| 39 | Compass Therapeutics, Inc. | CMPX | 5,005,086 | $5.0M | 0.78% |
| 40 | Adaptimmune Therapeutics plc | ADTI | 5,095,912 | $5.0M | 0.77% |
| 41 | Immatics NV | IMTX | 417,810 | $4.9M | 0.75% |
| 42 | Trevi Therapeutics Inc | TRVI | 1,510,174 | $4.5M | 0.70% |
| 43 | Verve Therapeutics, Inc | 92539P101 | 638,163 | $3.1M | 0.48% |
| 44 | Allakos | 01671P100 | 344,900 | $344,900 | 0.05% |